Department of Pharmacology, 9-31 Medical Sciences Building, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Can J Physiol Pharmacol. 2012 Jun;90(6):753-64. doi: 10.1139/y2012-076. Epub 2012 May 24.
Since the discovery that apolipoprotein E, a cholesterol transport protein, is a major risk factor for Alzheimer's disease (AD) development, there has been a remarkable interest in understanding the many facets of the relationship between cholesterol and AD. Several lines of evidence have demonstrated the importance of cholesterol in amyloid beta peptide (Aβ) production and metabolism, as well as the involvement of Aβ in cholesterol homeostasis. The emerging picture is complex and still incomplete. This review discusses findings that indicate that a reciprocal regulation exists between Aβ and cholesterol at the subcellular level. The pathological impact of such regulation is highlighted.
自发现载脂蛋白 E(一种胆固醇转运蛋白)是阿尔茨海默病(AD)发展的主要风险因素以来,人们对胆固醇与 AD 之间关系的多个方面产生了浓厚的兴趣。有几条证据表明胆固醇在淀粉样β肽(Aβ)的产生和代谢中很重要,以及 Aβ 参与胆固醇的动态平衡。目前的情况较为复杂,仍不完整。这篇综述讨论了表明 Aβ 和胆固醇在亚细胞水平存在相互调节的发现。强调了这种调节的病理影响。